查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1771577

美國經腸營養市場規模、佔有率、趨勢分析報告：按產品、流程類型、階段、適應症、最終用途、銷售管道、細分預測，2025-2030 年

U.S. Enteral Feeding Formulas Market Size, Share & Trends Analysis Report By Product, By Flow Type, By Stage, By Indication, By End use, By Sales Channel, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

市場規模與趨勢：

預計 2024 年美國經腸營養市場價值將達到 20.6 億美元，2025 年至 2030 年的複合年成長率將達到 5.7%。

癌症、中風、多發性硬化症、失智症、慢性肝病、慢性阻塞性肺病(COPD) 和糖尿病等慢性疾病的盛行率不斷上升，預計將增加對解決經口餵食難題的產品的需求。根據美國疾病管制與預防中心 (CDC) 2024 年 5 月發布的報告，美國約有 3,840 萬人患有糖尿病，約佔總人口的 11.96%。

阿茲海默症的盛行率不斷上升，推動了對經腸營養的需求。晚期患者常面臨吞嚥問題，需要營養補充。據美國疾病管制與預防中心稱，美國約有690萬人患有阿茲海默症。此外，到2022年，它將成為美國成年人第七大死因，也是65歲以上成年人第六大死因。美國老齡人口的不斷成長是推動經腸營養需求的另一個重要因素。隨著年齡的成長，人們通常會出現生理變化，例如食慾下降、吞嚥困難和消化效率降低，如果管理不當，會導致營養不良。經腸營養為確保老年人，特別是居住在輔助生活或長期照護機構的老年人獲得充足的營養攝取提供了實用的解決方案。

看護者和醫療保健提供者越來越意識到老年護理中早期營養干預的重要性，這進一步刺激了經腸營養產品的採用。

早產率的上升是推動口服餵食配方奶粉需求成長的關鍵因素之一，以滿足新生兒的營養需求。根據美國疾病管制與預防中心 (CDC) 2022 年的數據，美國每 10 個新生兒中約有 1 個是早產兒。此外，營養缺乏症和其他營養素缺乏症（包括微量營養素、蛋白質和其他營養素的嚴重缺乏，尤其是在嬰兒和孕婦中）的持續增加，導致對經腸營養奶粉的需求增加。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章市場變數、趨勢和範圍

  • 市場展望
  • 技術概述
  • 定價分析
  • 消費行為分析
    • 招募模式
    • 購買行為
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 產業挑戰
  • 商業環境分析
    • 波特五力分析
    • PESTLE分析
    • COVID-19的影響

第4章美國經腸營養市場：產品評估與趨勢分析

  • 細分儀表板
  • 經腸營養市場：2023 年和 2030 年產品變化分析
    • 標準
    • 疾病

第5章美國經腸營養市場：流量類型估計與趨勢分析

  • 細分儀表板
  • 經腸營養市場：2023 年和 2030 年流量類型變化分析
    • 間歇進料流量
    • 常規供應流

第6章：美國經腸營養市場：階段評估與趨勢分析

  • 細分儀表板
  • 經腸營養市場：2023 年和 2030 年階段變化分析
  • 成人
  • 孩子們

第7章美國經腸營養市場：適應症與趨勢分析

  • 細分儀表板
  • 經腸營養市場：2023年及2030年適應症變化分析
  • 阿茲海默症
  • 營養缺乏
    • 癌症護理
    • 糖尿病
    • 慢性腎臟病
    • 罕見疾病
    • 吞嚥問題
    • 疼痛管理
    • 吸收不良/胃腸道疾病/腹瀉
    • 其他

第8章美國經腸營養市場：最終用途估計與趨勢分析

  • 細分儀表板
  • 經腸營養市場：2023 年和 2030 年最終用途趨勢分析
    • 醫院
    • 居家護理

第9章美國經腸營養市場：銷售管道評估與趨勢分析

  • 細分儀表板
  • 經腸營養市場：2023 年和 2030 年銷售管道變化分析
    • 網上銷售
    • 零售銷售
    • 機構投資人銷售

第10章 競爭格局

  • 2024年公司市場佔有率分析（%）
  • 公司分類
  • 公司簡介/上市公司
    • Ajinomoto Cambrooke
    • Global Health Products, Inc.
    • Kate Farms
    • Abbott
    • Danone SA
    • Kabi AG
    • Nestle
    • Primus Pharmaceuticals, Inc.
    • Mead Johnson &Company, LLC
    • Alcresta Therapeutics
    • Real Food Blends
    • B. Braun SE
Product Code: GVR-4-68040-613-4

Market Size & Trends:

The U.S. enteral feeding formulas market size was estimated at USD 2.06 billion in 2024 and is projected to grow at a CAGR of 5.7% from 2025 to 2030. The increasing prevalence of chronic diseases, including cancer, stroke, multiple sclerosis, dementia, chronic liver disease, chronic obstructive pulmonary disease (COPD), and diabetes, is anticipated to increase the demand for products addressing oral intake challenges. The Centers for Disease Control and Prevention (CDC) reports published in May 2024 states that approximately 38.4 million people in U.S. have diabetes, which is around 11.96% of the overall population.

The growing prevalence of Alzheimer's disease is boosting demand for enteral feeding formulas, as patients in advanced stages often face difficulty in swallowing and require nutritional support. According to the CDC, around 6.9 million people in the U.S. are living with Alzheimer's disease. Furthermore, in 2022, it was the 7th leading cause of death among U.S. adults and the 6th leading cause of death among adults 65 years or older. The rising aging population in the U.S. is another key factor driving the demand for enteral feeding formulas. As individuals age, they often experience physiological changes such as reduced appetite, swallowing difficulties (dysphagia), and decreased digestive efficiency, leading to malnutrition if not properly managed. Enteral feeding provides a practical solution to ensure adequate nutrient intake among elderly individuals, particularly those residing in assisted living or long-term care facilities.

Increased awareness among caregivers and healthcare providers regarding the importance of early nutritional intervention in geriatric care is further fueling the adoption of enteral nutrition products.

Rise in preterm births is one of the significant factors boosting the demand for sip feeds to meet the nutritional requirements of newborns. According to the CDC in 2022, preterm birth affected about 1 of every 10 infants born in the U.S. In addition, the continued rise in nutritional and other deficiencies, including severe deficiency of micronutrients, proteins, and other nutrients, especially in infants and pregnant women, is leading to an increase in the demand for enteral feeding formulas.

U.S. Enteral Feeding Formulas Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. enteral feeding formulas market report based on product, flow type, stage, indication, end use, and sales channel.

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Standard Formula
  • Disease-specific Formulas
  • Flow Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Intermittent Feeding Flow
  • Continuous Feeding Flow
  • Stage Outlook (Revenue, USD Million, 2018 - 2030)
  • Adults
  • Pediatrics
  • Indication Outlook (Revenue, USD Million, 2018 - 2030)
  • Alzheimer's
  • Nutrition Deficiency
  • Cancer Care
  • Diabetes
  • Chronic Kidney Diseases
  • Orphan Diseases
  • Dysphagia
  • Pain Management
  • Malabsorption/GI Disorder/Diarrhea
  • Others
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
    • Cardiology
    • Neurology
    • Critical Care (ICU)
    • Oncology
    • Others
  • Home Care
  • Sales Channel Outlook (Revenue, USD Million, 2018 - 2030)
  • Online Sales
  • Retail Sales
  • Institutional Sales

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Flow Type
    • 1.2.3. Stage
    • 1.2.4. Indication
    • 1.2.5. End Use
    • 1.2.6. Sales Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Technology Overview
  • 3.3. Pricing Analysis
  • 3.4. Consumer Behavior Analysis
    • 3.4.1. Adoption Pattern
    • 3.4.2. Purchasing behaviors
  • 3.5. Market Dynamics
    • 3.5.1. Market Driver Analysis
      • 3.5.1.1. Rising geriatric population
      • 3.5.1.2. Growing prevalence of chronic diseases
      • 3.5.1.3. Shifting trend toward consumption of disease-specific formulas
      • 3.5.1.4. Growing demand for neonatal and preterm enteral feeding
    • 3.5.2. Market Restraint Analysis
      • 3.5.2.1. Lack of awareness in the medical community
      • 3.5.2.2. Improper categorization of clinical nutrition
    • 3.5.3. Market Opportunity Analysis
    • 3.5.4. Industry Challenges
      • 3.5.4.1. Complications associated with small-bore connectors
      • 3.5.4.2. Risks associated with enteral feeding
  • 3.6. Business Environment Analysis
    • 3.6.1. Porter's Five Forces Analysis
      • 3.6.1.1. Supplier power
      • 3.6.1.2. Buyer power
      • 3.6.1.3. Substitution threat
      • 3.6.1.4. Threat of new entrant
      • 3.6.1.5. Competitive rivalry
    • 3.6.2. PESTLE Analysis
      • 3.6.2.1. Political landscape
      • 3.6.2.2. Economic landscape
      • 3.6.2.3. Social landscape
      • 3.6.2.4. Technological landscape
      • 3.6.2.5. Environmental landscape
      • 3.6.2.6. Legal landscape
    • 3.6.3. Impact of COVID 19

Chapter 4. U.S. Enteral Feeding Formulas Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Enteral Feeding Formulas Market: Product Movement Analysis, 2023 & 2030 (USD Million)
    • 4.2.1. Standard formula
      • 4.2.1.1. Market Estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.2.2. Disease-specific formula
      • 4.2.2.1. Market Estimates and forecasts, 2018 - 2030(USD Million)

Chapter 5. U.S. Enteral Feeding Formulas Market: Flow Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Enteral Feeding Formulas Market: Flow Type Movement Analysis, 2023 & 2030 (USD Million)
    • 5.2.1. Intermittent Feeding Flow
      • 5.2.1.1. Market Estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.2.2. Continuous Feeding Flow
      • 5.2.2.1. Market Estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Enteral Feeding Formulas Market: Stage Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Enteral Feeding Formulas Market: Stage Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Adult
    • 6.3.1. Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.4. Pediatric
    • 6.4.1. Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Enteral Feeding Formulas Market: Indication Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Enteral Feeding Formulas Market: Indication Movement Analysis, 2023 & 2030 (USD Million)
  • 7.3. Alzheimer's Disease
    • 7.3.1. Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4. Nutrition Deficiency
    • 7.4.1. Nutrition Deficiency, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. Cancer Care
    • 7.4.3. Cancer Care, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Diabetes
    • 7.4.5. Diabetes, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Chronic Kidney Diseases
    • 7.4.7. Chronic Kidney Diseases, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.8. Orphan Diseases
    • 7.4.9. Orphan Diseases, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.10. Dysphagia
    • 7.4.11. Dysphagia, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.12. Pain Management
    • 7.4.13. Pain Management, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.14. Malabsorption/GI Disorder/Diarrhea
    • 7.4.15. Malabsorption/Gi Disorder/Diarrhea, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.16. Others
    • 7.4.17. Others Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. U.S. Enteral Feeding Formulas Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Enteral Feeding Formulas Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
    • 8.2.1. Hospitals
      • 8.2.1.1. Hospitals Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
      • 8.2.1.1.1.Cardiology
          • 8.2.1.1.1.1. Cardiology Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
      • 8.2.1.1.2.Neurology
          • 8.2.1.1.2.1. Neurology, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
      • 8.2.1.1.3.Critical Care (ICU)
          • 8.2.1.1.3.1. Critical Care (ICU) Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
      • 8.2.1.1.4.Oncology
          • 8.2.1.1.4.1. Oncology Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
      • 8.2.1.1.5.Others
          • 8.2.1.1.5.1. Others Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. Home Care
      • 8.2.2.1. Home Care Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. U.S. Enteral Feeding Formulas Market: Sales Channel Estimates & Trend Analysis

  • 9.1. Segment Dashboard
  • 9.2. Enteral Feeding Formulas Market: Sales Channel Movement Analysis, 2023 & 2030 (USD Million)
    • 9.2.1. Online Sales
      • 9.2.1.1. Online Sales Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.2.2. Retail Sales
      • 9.2.2.1. Retail Sales Market Revenue Estimates and forecasts, 2018 - 2030
    • 9.2.3. Institutional Sales
      • 9.2.3.1. Institutional Sales Market Revenue Estimates and forecasts, 2018 - 2030

Chapter 10. Competitive Landscape

  • 10.1. Company Market Share Analysis, 2024 (%)
  • 10.2. Company Categorization
  • 10.3. Company Profiles/Listing
    • 10.3.1. Ajinomoto Cambrooke
      • 10.3.1.1. Overview
      • 10.3.1.2. Financial performance
      • 10.3.1.3. Product benchmarking
      • 10.3.1.4. Strategic initiatives
    • 10.3.2. Global Health Products, Inc.
      • 10.3.2.1. Overview
      • 10.3.2.2. Financial performance
      • 10.3.2.3. Product benchmarking
      • 10.3.2.4. Strategic initiatives
    • 10.3.3. Kate Farms
      • 10.3.3.1. Overview
      • 10.3.3.2. Financial performance
      • 10.3.3.3. Product benchmarking
      • 10.3.3.4. Strategic initiatives
    • 10.3.4. Abbott
      • 10.3.4.1. Overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Product benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. Danone S.A
      • 10.3.5.1. Overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Product benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. Kabi AG
      • 10.3.6.1. Overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Product benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. Nestle
      • 10.3.7.1. Overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Product benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. Primus Pharmaceuticals, Inc.
      • 10.3.8.1. Overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Product benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. Mead Johnson & Company, LLC
      • 10.3.9.1. Overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Product benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. Alcresta Therapeutics
      • 10.3.10.1. Overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Product benchmarking
      • 10.3.10.4. Strategic initiatives
    • 10.3.11. Real Food Blends
      • 10.3.11.1. Overview
      • 10.3.11.2. Financial performance
      • 10.3.11.3. Product benchmarking
      • 10.3.11.4. Strategic initiatives
    • 10.3.12. B. Braun SE
      • 10.3.12.1. Overview
      • 10.3.12.2. Financial performance
      • 10.3.12.3. Product benchmarking
      • 10.3.12.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. U.S. Enteral feeding formulas market, Product, 2018 - 2030 (USD Million)
  • Table 4. U.S. Enteral feeding formulas market, by Flow Type, 2018 - 2030 (USD Million)
  • Table 5. U.S. Enteral feeding formulas market, by Stage, 2018 - 2030 (USD Million)
  • Table 6. U.S. Enteral feeding formulas market, by Indication, 2018 - 2030 (USD Million)
  • Table 7. U.S. Enteral feeding formulas market, by End Use, 2018 - 2030 (USD Million)
  • Table 8. U.S. Enteral feeding formulas market, by Sales Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market segmentation
  • Fig. 8 Market snapshot
  • Fig. 9 Segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Market trends & outlook
  • Fig. 12 Market driver relevance analysis (current & future impact)
  • Fig. 13 Market restraint relevance analysis (current & future impact)
  • Fig. 14 PESTLE analysis
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 U.S. Enteral feeding formulas market: Products movement analysis
  • Fig. 17 U.S. Enteral feeding formulas market: Products outlook and key takeaways
  • Fig. 18 Standard Formula market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Disease-Specific Formulas market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 U.S. Enteral feeding formulas market: Flow Type movement analysis
  • Fig. 21 U.S. Enteral feeding formulas market: Flow Type outlook and key takeaways
  • Fig. 22 Intermittent feeding flow market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Continuous feeding flow market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 U.S. Enteral feeding formulas market: Stage movement analysis
  • Fig. 25 U.S. Enteral feeding formulas market: Stage outlook and key takeaways
  • Fig. 26 Adults market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Pediatrics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 U.S. Enteral feeding formulas market: Indication movement analysis
  • Fig. 29 U.S. Enteral feeding formulas market: Indication outlook and key takeaways
  • Fig. 30 Alzheimer's market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Nutrition Deficiency market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Cancer Care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Chronic Kidney Diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Orphan Diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Dysphagia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Pain Management market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Malabsorption/GI Disorder/Diarrhea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. Enteral feeding formulas market: End Use movement analysis
  • Fig. 41 U.S. Enteral feeding formulas market: End Use outlook and key takeaways
  • Fig. 42 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Neurology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Critical Care (ICU) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Home Care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 U.S. Enteral feeding formulas market: Sales Channel movement analysis
  • Fig. 49 U.S. Enteral feeding formulas market: Sales Channel outlook and key takeaways
  • Fig. 50 Online sales market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Retail sales market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Institutional sales market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Market Participant Categorization
  • Fig. 54 Strategy mapping
  • Fig. 55 Company market position analysis